Cargando…
Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative Colitis
Fecal microbiota transplantation (FMT) has been recognized as a promising treatment for dysbiosis-related diseases. Since 2014, FMT has been utilized to treat ulcerative colitis (UC) in our clinical studies and has shown efficacy and safety. As donor screening (DS) is the primary step to ensure the...
Autores principales: | Zhang, Xiaochen, Ishikawa, Dai, Nomura, Kei, Fukuda, Naoyuki, Haraikawa, Mayuko, Haga, Keiichi, Shibuya, Tomoyoshi, Mita, Toshihiro, Nagahara, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879222/ https://www.ncbi.nlm.nih.gov/pubmed/35207328 http://dx.doi.org/10.3390/jcm11041055 |
Ejemplares similares
-
A Randomized Placebo-Controlled Trial of Combination Therapy With Post-triple-antibiotic-therapy Fecal Microbiota Transplantation and Alginate for Ulcerative Colitis: Protocol
por: Ishikawa, Dai, et al.
Publicado: (2022) -
Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Microbiota Transplantation
por: Okahara, Koki, et al.
Publicado: (2020) -
Differential diagnosis of ulcerative colitis with increased diarrhea;
collagenous colitis or irritable bowel syndrome? A case report
por: Haraikawa, Mayuko, et al.
Publicado: (2022) -
Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis
por: Haga, Keiichi, et al.
Publicado: (2020) -
Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis
por: Haga, Keiichi, et al.
Publicado: (2022)